Publication | Open Access
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
284
Citations
17
References
2022
Year
EudraCT: 2011-002026-52; ClinicalTrials.gov Identifier: NCT01526135.
| Year | Citations | |
|---|---|---|
Page 1
Page 1